Average Insider

Where insiders trade, we follow

Insider Buy/Sell Details for the Healthcare Sector — March 2026

Extreme outlier transactions (>3σ) are excluded.Show All Data
Ratio0.1:1
Daily Buy & Sell Volume

VERACYTE, INC. (VCYT)

Leite John — Chief Commercial Officer-CLIA
Mar 4, 2026
Sale
Shares
5,260
Price
$35.19
Total Value
$185.08K
Shares Held After
107,580
% of Holdings
4.7%

VERACYTE, INC. (VCYT)

McGuire Annie — SVP, General Counsel
Mar 4, 2026
Sale
Shares
1,664
Price
$36.34
Total Value
$60.47K
Shares Held After
94,706
% of Holdings
1.7%

VERACYTE, INC. (VCYT)

McGuire Annie — SVP, General Counsel
Mar 4, 2026
Sale
Shares
4,994
Price
$35.29
Total Value
$176.26K
Shares Held After
96,370
% of Holdings
4.9%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Poulton Jeffrey V. — EVP, Chief Financial Officer
Mar 4, 2026
Sale
Shares
223
Price
$325.67
Total Value
$72.62K
Shares Held After
61,805
% of Holdings
0.4%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Poulton Jeffrey V. — EVP, Chief Financial Officer
Mar 4, 2026
Sale
Shares
291
Price
$324.88
Total Value
$94.54K
Shares Held After
62,028
% of Holdings
0.5%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Poulton Jeffrey V. — EVP, Chief Financial Officer
Mar 4, 2026
Sale
Shares
818
Price
$323.84
Total Value
$264.90K
Shares Held After
62,319
% of Holdings
1.3%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Poulton Jeffrey V. — EVP, Chief Financial Officer
Mar 4, 2026
Sale
Shares
374
Price
$323.01
Total Value
$120.81K
Shares Held After
63,137
% of Holdings
0.6%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Poulton Jeffrey V. — EVP, Chief Financial Officer
Mar 4, 2026
Sale
Shares
309
Price
$321.82
Total Value
$99.44K
Shares Held After
63,511
% of Holdings
0.5%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Poulton Jeffrey V. — EVP, Chief Financial Officer
Mar 4, 2026
Sale
Shares
230
Price
$320.81
Total Value
$73.79K
Shares Held After
63,820
% of Holdings
0.4%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Poulton Jeffrey V. — EVP, Chief Financial Officer
Mar 4, 2026
Sale
Shares
109
Price
$320.01
Total Value
$34.88K
Shares Held After
64,050
% of Holdings
0.2%
Mar 4, 2026
Sale
Shares
2,425
Price
$12.92
Total Value
$31.32K
Shares Held After
91,109
% of Holdings
2.6%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Poulton Jeffrey V. — EVP, Chief Financial Officer
Mar 4, 2026
Sale
Shares
114
Price
$319.03
Total Value
$36.37K
Shares Held After
64,159
% of Holdings
0.2%

PepGen Inc. (PEPG)

STRECK PAUL — EVP, Head of R&D
Mar 4, 2026
Sale
Shares
47
Price
$6.29
Total Value
$295.54
Shares Held After
76,226
% of Holdings
0.1%

PepGen Inc. (PEPG)

STRECK PAUL — EVP, Head of R&D
Mar 4, 2026
Sale
Shares
1,832
Price
$6.23
Total Value
$11.41K
Shares Held After
76,273
% of Holdings
2.3%
Mar 4, 2026
Sale
Shares
6,189
Price
$12.92
Total Value
$79.94K
Shares Held After
326,167
% of Holdings
1.9%
Mar 4, 2026
Sale
Shares
15,793
Price
$27.53
Total Value
$434.78K
Shares Held After
16,026
% of Holdings
49.6%
Mar 4, 2026
Sale
Shares
1,171
Price
$12.92
Total Value
$15.12K
Shares Held After
165,859
% of Holdings
0.7%

Orthofix Medical Inc. (OFIX)

Fisher Patrick — President, Global Limb Recon
Mar 4, 2026
Sale
Shares
778
Price
$12.92
Total Value
$10.05K
Shares Held After
51,391
% of Holdings
1.5%

Neuronetics, Inc. (STIM)

MACAN WILLIAM ANDREW — EVP, CLO and CS
Mar 4, 2026
Sale
Shares
609
Price
$1.34
Total Value
$816.06
Shares Held After
879,525
% of Holdings
0.1%
Mar 4, 2026
Sale
Shares
208
Price
$325.67
Total Value
$67.74K
Shares Held After
21,097
% of Holdings
1.0%
Mar 4, 2026
Sale
Shares
272
Price
$324.88
Total Value
$88.37K
Shares Held After
21,305
% of Holdings
1.3%
Mar 4, 2026
Sale
Shares
767
Price
$323.84
Total Value
$248.39K
Shares Held After
21,577
% of Holdings
3.4%
Mar 4, 2026
Sale
Shares
350
Price
$323.01
Total Value
$113.05K
Shares Held After
22,344
% of Holdings
1.5%
Mar 4, 2026
Sale
Shares
289
Price
$321.82
Total Value
$93.01K
Shares Held After
22,694
% of Holdings
1.3%
Mar 4, 2026
Sale
Shares
215
Price
$320.81
Total Value
$68.97K
Shares Held After
22,983
% of Holdings
0.9%
Mar 4, 2026
Sale
Shares
102
Price
$320.01
Total Value
$32.64K
Shares Held After
23,198
% of Holdings
0.4%
Mar 4, 2026
Sale
Shares
106
Price
$319.03
Total Value
$33.82K
Shares Held After
23,300
% of Holdings
0.5%

QUEST DIAGNOSTICS INC (DGX)

KUPPUSAMY KARTHIK — SVP, Clinical Solutions
Mar 4, 2026
Sale
Shares
2,628
Price
$204.86
Total Value
$538.37K
Shares Held After
13,441
% of Holdings
16.4%
Mar 4, 2026
Sale
Shares
64,921
Price
$64.87
Total Value
$4.21M
Shares Held After
18,589
% of Holdings
77.7%

VERACYTE, INC. (VCYT)

Chambers Rebecca — Chief Financial Officer
Mar 4, 2026
Sale
Shares
13,941
Price
$36.33
Total Value
$506.46K
Shares Held After
131,196
% of Holdings
9.6%

VERACYTE, INC. (VCYT)

Chambers Rebecca — Chief Financial Officer
Mar 4, 2026
Sale
Shares
4,400
Price
$35.55
Total Value
$156.41K
Shares Held After
145,137
% of Holdings
2.9%
Mar 4, 2026
Sale
Shares
23,393
Price
$32.46
Total Value
$759.44K
Shares Held After
1,148,212
% of Holdings
2.0%
Mar 4, 2026
Sale
Shares
265
Price
$325.67
Total Value
$86.30K
Shares Held After
95,695
% of Holdings
0.3%
Mar 4, 2026
Sale
Shares
345
Price
$324.88
Total Value
$112.08K
Shares Held After
95,960
% of Holdings
0.4%
Mar 4, 2026
Sale
Shares
973
Price
$323.84
Total Value
$315.10K
Shares Held After
96,305
% of Holdings
1.0%
Mar 4, 2026
Sale
Shares
444
Price
$323.01
Total Value
$143.42K
Shares Held After
97,278
% of Holdings
0.5%
Mar 4, 2026
Sale
Shares
368
Price
$321.82
Total Value
$118.43K
Shares Held After
97,722
% of Holdings
0.4%
Mar 4, 2026
Sale
Shares
274
Price
$320.81
Total Value
$87.90K
Shares Held After
98,090
% of Holdings
0.3%
Mar 4, 2026
Sale
Shares
129
Price
$320.01
Total Value
$41.28K
Shares Held After
98,364
% of Holdings
0.1%
Mar 4, 2026
Sale
Shares
135
Price
$319.03
Total Value
$43.07K
Shares Held After
98,493
% of Holdings
0.1%
Mar 4, 2026
Sale
Shares
1,193
Price
$149.62
Total Value
$178.50K
Shares Held After
2,866
% of Holdings
29.4%
Mar 4, 2026
Sale
Shares
11,277
Price
$32.46
Total Value
$366.10K
Shares Held After
97,590
% of Holdings
10.4%

Schrödinger, Inc. (SDGR)

Abel Robert Lorne — EVP, Chief Scientific Officer, Platform
Mar 4, 2026
Sale
Shares
1,300
Price
$12.81
Total Value
$16.65K
Shares Held After
55,897
% of Holdings
2.3%

TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)

Fox Christine — EVP, U.S. Commercial
Mar 4, 2026
Sale
Shares
9,098
Price
$32.46
Total Value
$295.36K
Shares Held After
75,010
% of Holdings
10.8%
Mar 4, 2026
Sale
Shares
1,405
Price
$12.92
Total Value
$18.15K
Shares Held After
64,119
% of Holdings
2.1%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Tanguler Tolga — EVP, Chief Commercial Officer
Mar 4, 2026
Sale
Shares
208
Price
$325.67
Total Value
$67.74K
Shares Held After
34,297
% of Holdings
0.6%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Tanguler Tolga — EVP, Chief Commercial Officer
Mar 4, 2026
Sale
Shares
272
Price
$324.88
Total Value
$88.37K
Shares Held After
34,505
% of Holdings
0.8%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Tanguler Tolga — EVP, Chief Commercial Officer
Mar 4, 2026
Sale
Shares
767
Price
$323.84
Total Value
$248.39K
Shares Held After
34,777
% of Holdings
2.2%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Tanguler Tolga — EVP, Chief Commercial Officer
Mar 4, 2026
Sale
Shares
350
Price
$323.01
Total Value
$113.05K
Shares Held After
35,544
% of Holdings
1.0%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Tanguler Tolga — EVP, Chief Commercial Officer
Mar 4, 2026
Sale
Shares
289
Price
$321.82
Total Value
$93.01K
Shares Held After
35,894
% of Holdings
0.8%
Version: v26.3.33